Skip to main content
NSE - SMEListed
Mono Pharmacare Limited Logo

Mono Pharmacare Limited IPO

Mono Pharmacare Limited IPO

IPO Date :
Issue Price :
Allotment Date :
Listing Date :
List Price :
Lot Size:
Subscription:
Listed Price: ₹ 29.00 (+3.57%)

The public market debut of Mono Pharmacare Limited's was completed on 07-09-2023 with its listing on the NSE exchange. The IPO process raised 53,00,000 Shares in total capital, consisting of 53,00,000 Shares in new equity.

The offering featured a price range of ₹26 to ₹28 and minimum application size of 4000 shares. Investor response during the subscription period from 28-08-2023 to 30-08-2023 influenced the final allotment ratios across investor categories.

Final allotment was announced on 04-09-2023, distributing shares to successful subscribers. The listing established a continuous market for the company's shares, enabling liquidity, valuation transparency, and broader investor participation.

Mono Pharmacare IPO Details
Lot(s) Distribution

Investors can bid starting from the minimum lot size specified for this IPO, and only in multiples of that lot size. The table below shows the minimum and maximum investment for retail investors and HNIs in terms of lots, quantity, and amount.

IPO Reservation
Mono Pharmacare IPO Key Performance Indicator
Company Financials ( in Lakhs )

Mono Pharmacare IPO About Company

Incorporated in 1994, Mono Pharmacare Limited is engaged in the marketing and distribution of pharmaceutical products, offering a wide range of medicines and healthcare items including antibiotics, allergy & cough medicines, antifungals, nutraceuticals, pain relievers, antacids, antiemetics, and cardiac-diabetic medicines, along with cosmocare products. The company sells products under its brand “DLS Export”, which it acquired in 2022 for ₹609 lakhs to expand its product portfolio. As of February 28, 2023, Mono Pharmacare works with more than 168 pharmaceutical distributors & stockists and serves over 3,036 customers across retail pharmacy stores and wholesalers.


Note : "Calculations for ‘Shares Offered’ and ‘Total Amount’ are based on the highest price in the issue price band."


Mono Pharmacare IPO Strength Factors

NA


Mono Pharmacare IPO Risk Factors

NA


Mono Pharmacare IPO Lead Manager(s)

  • Unistone Capital Private Limited

Mono Pharmacare IPO Promoter(s)

  1. Panilam Lakhatariya
  2. Supal Lakhatariya

Mono Pharmacare IPO Company Details

Mono Pharmacare Limited
Phone:
address:

Mono Pharmacare IPO Registrar

Bigshare Services Private Limited
Name:
Phone:

Mono Pharmacare IPO FAQs